Health Phathom Pharmaceuticals Provides Update on Litigation Filed by BDR Pharmaceuticals against FDA October 23, 2026
Biotech ORIC® Pharmaceuticals Presents Potential Best-in-Class Data for Enozertinib in 1L NSCLC Patients with EGFR Atypical Mutations at ESMO Congress 2026 and Plans to Advance Enozertinib into a Global Phase 3 Trial October 23, 2026
Biotech ORIC® Pharmaceuticals Presents Preclinical and Translational Data to Support the Potential of Rinzimetostat to Enhance Sensitivity to Androgen Receptor Inhibition in Prostate Cancer at ESMO Congress 2026 October 23, 2026
Technology MicroVision Begins Commercial Production of MOVIA(TM) Pro to Meet Immediate Customer Demand for Superior Short-Range Sensing and Onboard Perception, Enabling Physical AI at the Edge October 22, 2026
Biotech Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01 October 22, 2026
Search
pr
October 23, 2026
October 23, 2026
October 23, 2026
October 23, 2026
October 23, 2026
October 22, 2026
October 22, 2026
October 22, 2026
October 22, 2026
October 22, 2026
